FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065005286> ?p ?o ?g. }

• W2065005286 endingPage "1563" @default.
• W2065005286 startingPage "1554" @default.
• W2065005286 abstract "OBJECTIVES We sought to determine whether potassium (K + ) channel blockers (KBs) can activate extracellular signal-regulated kinase (ERK) and to characterize the upstream signals leading to ERK activation in cardiomyocytes. BACKGROUND Because KBs attenuate K + outward current, they may possibly prolong the duration of action potentials, leading to an increase in calcium (Ca 2+ ) transient ([Ca 2+ ] i ) in cardiomyocytes. Elevation of intracellular Ca 2+ levels can trigger various signaling events. Influx of Ca 2+ through L-type Ca 2+ channels after membrane depolarization induced activation of MEK and ERK through activation of Ras in neurons. Although KBs are frequently used to treat cardiac arrhythmias, their effect on signaling pathways remains unknown. METHODS Primary cultured rat cardiomyocytes were stimulated with four different KBs—4-aminopyridine (4-AP), E-4031, tetra-ethylammonium and quinidine—and phosphorylation of ERK, proline-rich tyrosine kinase 2 (Pyk2) and epidermal growth factor receptor (EGFR) was detected. Action potentials were recorded by use of a conventional microelectrode. (Ca 2+ ) i was monitored by the fluorescent calcium indicator Fluo-4. RESULTS E-4031, 4-AP, tetra-ethylammonium and quinidine induced phosphorylation of ERK. 4-Aminopyridine prolonged the duration of action potentials by 37% and increased (Ca 2+ ) i by 52% at 1 mmol/l. Pre-incubation of ethyleneglycoltetraacetic acid, 1,2-bis(2-aminophenoxy)-ethane-N,N,N′,N′-tetraacetic acid tetrakis and diltiazem completely blocked this phosphorylation, whereas flufenamic acid and benzamil did not. 4-Aminopyridine induced tyrosine phosphorylation of Pyk2 and EGFR, which peaked at 5 and 10 min, respectively. Cytochalasin D, AG1478 and dominant-negative EGFR strongly inhibited the phosphorylation of ERK, whereas calphostin C, calmidazolium and KN62 did not. CONCLUSIONS These findings indicate that KBs induce ERK activation, which starts with Ca 2+ entry through the L-type Ca 2+ channel in cardiomyocytes, and that EGFR and Pyk2 are involved in this activation." @default.
• W2065005286 created "2016-06-24" @default.
• W2065005286 creator A5046033589 @default.
• W2065005286 creator A5061483126 @default.
• W2065005286 creator A5066866386 @default.
• W2065005286 creator A5069453818 @default.
• W2065005286 creator A5086034121 @default.
• W2065005286 creator A5089698034 @default.
• W2065005286 date "2001-11-01" @default.
• W2065005286 modified "2023-09-30" @default.
• W2065005286 title "Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes" @default.
• W2065005286 cites W1573821584 @default.
• W2065005286 cites W1911507086 @default.
• W2065005286 cites W1966635630 @default.
• W2065005286 cites W1967463041 @default.
• W2065005286 cites W1968672667 @default.
• W2065005286 cites W1970328692 @default.
• W2065005286 cites W1976498439 @default.
• W2065005286 cites W1992738986 @default.
• W2065005286 cites W1996736723 @default.
• W2065005286 cites W1999788892 @default.
• W2065005286 cites W2010739912 @default.
• W2065005286 cites W2018519338 @default.
• W2065005286 cites W2021564846 @default.
• W2065005286 cites W2027887411 @default.
• W2065005286 cites W2042629507 @default.
• W2065005286 cites W2048050231 @default.
• W2065005286 cites W2051493425 @default.
• W2065005286 cites W2057203237 @default.
• W2065005286 cites W2066900054 @default.
• W2065005286 cites W2071666526 @default.
• W2065005286 cites W2076544187 @default.
• W2065005286 cites W2092349073 @default.
• W2065005286 cites W2093223195 @default.
• W2065005286 cites W2098624213 @default.
• W2065005286 cites W2102564220 @default.
• W2065005286 cites W2125426078 @default.
• W2065005286 cites W2125797096 @default.
• W2065005286 cites W2131407502 @default.
• W2065005286 cites W2170247538 @default.
• W2065005286 cites W2181870051 @default.
• W2065005286 doi "https://doi.org/10.1016/s0735-1097(01)01558-3" @default.
• W2065005286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11691539" @default.
• W2065005286 hasPublicationYear "2001" @default.
• W2065005286 type Work @default.
• W2065005286 sameAs 2065005286 @default.
• W2065005286 citedByCount "26" @default.
• W2065005286 countsByYear W20650052862012 @default.
• W2065005286 countsByYear W20650052862013 @default.
• W2065005286 countsByYear W20650052862014 @default.
• W2065005286 countsByYear W20650052862016 @default.
• W2065005286 countsByYear W20650052862017 @default.
• W2065005286 countsByYear W20650052862019 @default.
• W2065005286 countsByYear W20650052862020 @default.
• W2065005286 countsByYear W20650052862021 @default.
• W2065005286 crossrefType "journal-article" @default.
• W2065005286 hasAuthorship W2065005286A5046033589 @default.
• W2065005286 hasAuthorship W2065005286A5061483126 @default.
• W2065005286 hasAuthorship W2065005286A5066866386 @default.
• W2065005286 hasAuthorship W2065005286A5069453818 @default.
• W2065005286 hasAuthorship W2065005286A5086034121 @default.
• W2065005286 hasAuthorship W2065005286A5089698034 @default.
• W2065005286 hasBestOaLocation W20650052861 @default.
• W2065005286 hasConcept C11960822 @default.
• W2065005286 hasConcept C126322002 @default.
• W2065005286 hasConcept C134018914 @default.
• W2065005286 hasConcept C153461711 @default.
• W2065005286 hasConcept C184235292 @default.
• W2065005286 hasConcept C185592680 @default.
• W2065005286 hasConcept C195794163 @default.
• W2065005286 hasConcept C28406088 @default.
• W2065005286 hasConcept C42362537 @default.
• W2065005286 hasConcept C519063684 @default.
• W2065005286 hasConcept C57074206 @default.
• W2065005286 hasConcept C62478195 @default.
• W2065005286 hasConcept C71924100 @default.
• W2065005286 hasConcept C86803240 @default.
• W2065005286 hasConcept C95444343 @default.
• W2065005286 hasConcept C98274493 @default.
• W2065005286 hasConceptScore W2065005286C11960822 @default.
• W2065005286 hasConceptScore W2065005286C126322002 @default.
• W2065005286 hasConceptScore W2065005286C134018914 @default.
• W2065005286 hasConceptScore W2065005286C153461711 @default.
• W2065005286 hasConceptScore W2065005286C184235292 @default.
• W2065005286 hasConceptScore W2065005286C185592680 @default.
• W2065005286 hasConceptScore W2065005286C195794163 @default.
• W2065005286 hasConceptScore W2065005286C28406088 @default.
• W2065005286 hasConceptScore W2065005286C42362537 @default.
• W2065005286 hasConceptScore W2065005286C519063684 @default.
• W2065005286 hasConceptScore W2065005286C57074206 @default.
• W2065005286 hasConceptScore W2065005286C62478195 @default.
• W2065005286 hasConceptScore W2065005286C71924100 @default.
• W2065005286 hasConceptScore W2065005286C86803240 @default.
• W2065005286 hasConceptScore W2065005286C95444343 @default.
• W2065005286 hasConceptScore W2065005286C98274493 @default.
• W2065005286 hasIssue "5" @default.
• W2065005286 hasLocation W20650052861 @default.
• W2065005286 hasLocation W20650052862 @default.

• next